Login
← Go Back
Alivus Life Sciences
GLS · Pharma > Pharmaceuticals & Drugs · Chairman: Glenn Saldanha · MD: Yasir Rawjee · Listing date: Aug. 7, 2021 · Employees: 1537 · Mumbai · http://www.glenmarklifesciences.com
Stock Price vs Company Growth
1d
0.5%
1w
0.6%
1m
6.6%
3m
12.0%
6m
22.1%
1y
57.6%
all
13.6%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,013 0.5%
936
1,222
Company Overview
Sales
2,205 Cr
Growth: 1.5%
Profit after Tax
424 Cr
Growth: -5.2%
Mid Cap
12,407 Cr
P/E: 29.4x
Industry P/E: 37.3x
Fundamentals
Sales (Cr) ₹ 2,205
Growth 1.5%
EBITDA 27.6%
P/S 5.6x
Dividend 3.4%
P/E 29.4x
Book Value ₹ 207
PEG Ratio 19.6x
ROE 17.2%
P/B 4.9x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is in the business of making high-quality drugs by unlocking the possibilities of science.Awards, accreditations and recognitions2015: Ankleshwar plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Dahej plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Ankleshwar plant received BS OHSAS 18001:2017 certifying the management system of the manufacturing facility.
Belongs to (9 Indices) view more
Investors (5)
nirma
polar.ca...
societe....
Followers (1)
atharav